Skip to main content
Erschienen in: International Urology and Nephrology 1/2024

05.09.2023 | Urology - Original Paper

Complications of tubeless versus standard percutaneous nephrolithotomy

verfasst von: Hayden Hill, Susan Talamini, Joel Vetter, Charles Nottingham

Erschienen in: International Urology and Nephrology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The necessity of nephrostomy tube after percutaneous nephrolithotomy (PCNL) has been called into question in modern series. We sought to examine differences in postoperative complications and outcomes of tubeless PCNL versus standard PCNL at our institution.

Methods

A retrospective review of our institutional stone database was conducted from January 2016 to December 2021 for patients who had undergone either tubeless PCNL, defined by placement of only an internal ureteral stent, or standard PCNL, which involved placement of an externalized nephrostomy tube. Patients were excluded if they underwent totally tubeless PCNL.

Results

A total of 438 patients were included for analysis: 329 patients underwent tubeless PCNL and 109 patients underwent standard PCNL. Between tubeless and standard groups, there was no difference in readmission rates 6.1% vs. 9.2% (p = 0.268), Clavien 2 or > complications 18.5% vs. 19.3% (p = 0.923), and Clavien 3 or > complications 4.0% vs. 7.3% (p = 0.151). The tubeless group experienced shorter operative duration 121.5 vs. 144.8 min (p = 0.012), shorter length of stay 2.5 vs. 3.8 days (p = 0.002), and higher stone-free rates 72.3% vs. 60.2% (p = 0.014), but also increased blood transfusion rates 6.4% vs. 0.9% (p = 0.022).

Conclusion

In comparing tubeless with standard PCNL, there was no difference in readmission rates, or significant Clavien complication rates. Patients undergoing tubeless PCNL experienced higher stone-free rates, but more number of patients required postoperative blood transfusion. The decision to leave a nephrostomy tube after PCNL appears unlikely to impact overall complication rates and can be left to surgeon experience and case-based discretion.
Literatur
1.
Zurück zum Zitat Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000CrossRefPubMed Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000CrossRefPubMed
2.
Zurück zum Zitat Geraghty RM, Jones P, Somani BK (2017) Worldwide trends of urinary stone disease treatment over the last two decades: a systematic review. J Endourol 31(6):547–556CrossRefPubMed Geraghty RM, Jones P, Somani BK (2017) Worldwide trends of urinary stone disease treatment over the last two decades: a systematic review. J Endourol 31(6):547–556CrossRefPubMed
3.
Zurück zum Zitat Bellman GC, Davidoff R, Candela J, Gerspach J, Kurtz S, Stout L (1997) Tubeless percutaneous renal surgery. J Urol 157(5):1578–1582CrossRefPubMed Bellman GC, Davidoff R, Candela J, Gerspach J, Kurtz S, Stout L (1997) Tubeless percutaneous renal surgery. J Urol 157(5):1578–1582CrossRefPubMed
4.
Zurück zum Zitat Chalise PR, Luitel B, Chapagain S, Poudyal S, Gyawali PR, Sharma UK et al (2017) Is nephrostomy tube a rule following all percutaneous nephrolithotomy (PCNL)? A prospective randomized study. J Soc Surg Nepal 20(2):43–48CrossRef Chalise PR, Luitel B, Chapagain S, Poudyal S, Gyawali PR, Sharma UK et al (2017) Is nephrostomy tube a rule following all percutaneous nephrolithotomy (PCNL)? A prospective randomized study. J Soc Surg Nepal 20(2):43–48CrossRef
5.
Zurück zum Zitat Moosanejad N, Firouzian A, Hashemi SA, Bahari M, Fazli M (2016) Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial. Braz J Med Biol Res 49(4):e4878CrossRefPubMedPubMedCentral Moosanejad N, Firouzian A, Hashemi SA, Bahari M, Fazli M (2016) Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial. Braz J Med Biol Res 49(4):e4878CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tirtayasa PMW, Yuri P, Birowo P, Rasyid N (2017) Safety of tubeless or totally tubeless drainage and nephrostomy tube as a drainage following percutaneous nephrolithotomy: a comprehensive review. Asian J Surg 40(6):419–423CrossRefPubMed Tirtayasa PMW, Yuri P, Birowo P, Rasyid N (2017) Safety of tubeless or totally tubeless drainage and nephrostomy tube as a drainage following percutaneous nephrolithotomy: a comprehensive review. Asian J Surg 40(6):419–423CrossRefPubMed
7.
Zurück zum Zitat Gauhar V, Traxer O, GarcíaRojo E, Scarcella S, Pavia MP, Chan VWS et al (2022) Complications and outcomes of tubeless versus nephrostomy tube in percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized clinical trials. Urolithiasis 50(5):511–522CrossRefPubMedPubMedCentral Gauhar V, Traxer O, GarcíaRojo E, Scarcella S, Pavia MP, Chan VWS et al (2022) Complications and outcomes of tubeless versus nephrostomy tube in percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized clinical trials. Urolithiasis 50(5):511–522CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chen ZJ, Yan YJ, Zhou JJ (2020) Comparison of tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a meta-analysis of randomized trials. Asian J Surg 43(1):60–68CrossRefPubMed Chen ZJ, Yan YJ, Zhou JJ (2020) Comparison of tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a meta-analysis of randomized trials. Asian J Surg 43(1):60–68CrossRefPubMed
9.
Zurück zum Zitat Xun Y, Wang Q, Hu H, Lu Y, Zhang J, Qin B et al (2017) Tubeless versus standard percutaneous nephrolithotomy: an update meta-analysis. BMC Urol 17(1):102CrossRefPubMedPubMedCentral Xun Y, Wang Q, Hu H, Lu Y, Zhang J, Qin B et al (2017) Tubeless versus standard percutaneous nephrolithotomy: an update meta-analysis. BMC Urol 17(1):102CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lee JY, Jeh SU, Kim MD, Kang DH, Kwon JK, Ham WS et al (2017) Intraoperative and postoperative feasibility and safety of total tubeless, tubeless, small-bore tube, and standard percutaneous nephrolithotomy: a systematic review and network meta-analysis of 16 randomized controlled trials. BMC Urol 17(1):48CrossRefPubMedPubMedCentral Lee JY, Jeh SU, Kim MD, Kang DH, Kwon JK, Ham WS et al (2017) Intraoperative and postoperative feasibility and safety of total tubeless, tubeless, small-bore tube, and standard percutaneous nephrolithotomy: a systematic review and network meta-analysis of 16 randomized controlled trials. BMC Urol 17(1):48CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Patel SR, Nakada SY (2015) The modern history and evolution of percutaneous nephrolithotomy. J Endourol 29(2):153–157CrossRefPubMed Patel SR, Nakada SY (2015) The modern history and evolution of percutaneous nephrolithotomy. J Endourol 29(2):153–157CrossRefPubMed
12.
Zurück zum Zitat Feng MI, Tamaddon K, Mikhail A, Kaptein JS, Bellman GC (2001) Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology 58(3):345–350CrossRefPubMed Feng MI, Tamaddon K, Mikhail A, Kaptein JS, Bellman GC (2001) Prospective randomized study of various techniques of percutaneous nephrolithotomy. Urology 58(3):345–350CrossRefPubMed
13.
Zurück zum Zitat Desai MR, Kukreja RA, Desai MM, Mhaskar SS, Wani KA, Patel SH et al (2004) A prospective randomized comparison of type of nephrostomy drainage following percutaneous nephrostolithotomy: large bore versus small bore versus tubeless. J Urol 172(2):565–567CrossRefPubMed Desai MR, Kukreja RA, Desai MM, Mhaskar SS, Wani KA, Patel SH et al (2004) A prospective randomized comparison of type of nephrostomy drainage following percutaneous nephrostolithotomy: large bore versus small bore versus tubeless. J Urol 172(2):565–567CrossRefPubMed
14.
Zurück zum Zitat Aghamir SMK, Hosseini SR, Gooran S (2004) Totally tubeless percutaneous nephrolithotomy. J Endourol 18(7):647–648CrossRefPubMed Aghamir SMK, Hosseini SR, Gooran S (2004) Totally tubeless percutaneous nephrolithotomy. J Endourol 18(7):647–648CrossRefPubMed
15.
Zurück zum Zitat Choi SW, Kim KS, Kim JH, Park YH, Bae WJ, Hong SH et al (2014) Totally tubeless versus standard percutaneous nephrolithotomy for renal stones: analysis of clinical outcomes and cost. J Endourol 28(12):1487–1494CrossRefPubMed Choi SW, Kim KS, Kim JH, Park YH, Bae WJ, Hong SH et al (2014) Totally tubeless versus standard percutaneous nephrolithotomy for renal stones: analysis of clinical outcomes and cost. J Endourol 28(12):1487–1494CrossRefPubMed
16.
Zurück zum Zitat Kr S, Singh A, Sharma P, Pai V, Choudhary A, Patil S (2023) Comparing tubeless and tubed approaches in percutaneous nephrolithotomy for moderate renal calculi: outcomes on safety, efficacy, pain management, recovery time, and cost-effectiveness. Cureus 15(5):e39211PubMedPubMedCentral Kr S, Singh A, Sharma P, Pai V, Choudhary A, Patil S (2023) Comparing tubeless and tubed approaches in percutaneous nephrolithotomy for moderate renal calculi: outcomes on safety, efficacy, pain management, recovery time, and cost-effectiveness. Cureus 15(5):e39211PubMedPubMedCentral
17.
Zurück zum Zitat Kumar S, Singh S, Singh P, Singh SK (2016) Day care PNL using “Santosh-PGI hemostatic seal” versus standard PNL: a randomized controlled study. Cent Eur J Urol 69(2):190–197 Kumar S, Singh S, Singh P, Singh SK (2016) Day care PNL using “Santosh-PGI hemostatic seal” versus standard PNL: a randomized controlled study. Cent Eur J Urol 69(2):190–197
18.
Zurück zum Zitat Kara C, Resorlu B, Bayindir M, Unsal A (2010) A randomized comparison of totally tubeless and standard percutaneous nephrolithotomy in elderly patients. Urology 76(2):289–293CrossRefPubMed Kara C, Resorlu B, Bayindir M, Unsal A (2010) A randomized comparison of totally tubeless and standard percutaneous nephrolithotomy in elderly patients. Urology 76(2):289–293CrossRefPubMed
19.
Zurück zum Zitat Etemadian M, Soleimani MJ, Haghighi R, Zeighami MR, Najimi N (2011) Does bleeding during percutaneous nephrolithotomy necessitate keeping the nephrostomy tube? A randomized controlled clinical trial. Urol J 8(1):21–26PubMed Etemadian M, Soleimani MJ, Haghighi R, Zeighami MR, Najimi N (2011) Does bleeding during percutaneous nephrolithotomy necessitate keeping the nephrostomy tube? A randomized controlled clinical trial. Urol J 8(1):21–26PubMed
20.
Zurück zum Zitat Shen P, Liu Y, Wang J (2012) Nephrostomy tube-free versus nephrostomy tube for renal drainage after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urol Int 88(3):298–306CrossRefPubMed Shen P, Liu Y, Wang J (2012) Nephrostomy tube-free versus nephrostomy tube for renal drainage after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urol Int 88(3):298–306CrossRefPubMed
Metadaten
Titel
Complications of tubeless versus standard percutaneous nephrolithotomy
verfasst von
Hayden Hill
Susan Talamini
Joel Vetter
Charles Nottingham
Publikationsdatum
05.09.2023
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2024
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03772-1

Weitere Artikel der Ausgabe 1/2024

International Urology and Nephrology 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.